Hospira Cisplatin 1mg/mL Concentrate for Solution for Infusion 50mg/50mL vial

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

cisplatin, Quantity: 1 mg/mL

Pieejams no:

Hospira Australia Pty Ltd

SNN (starptautisko nepatentēto nosaukumu):

Cisplatin

Zāļu forma:

Injection, intravenous infusion

Kompozīcija:

Excipient Ingredients: mannitol; sodium chloride; water for injections; hydrochloric acid; sodium hydroxide

Ievadīšanas:

Intravenous Infusion

Vienības iepakojumā:

1x 50mL pack

Klase:

Medicine Listed (Export Only)

Receptes veids:

(S1) This Schedule is intentionally blank

Ārstēšanas norādes:

Cisplatin is used in the treatment of certain types of cancer, for example ovarian cancer, testicular cancer, bladder cancer and head and neck cancer. Cisplatin may be used in combination with other anti-cancer medicines.

Produktu pārskats:

Visual Identification: A clear, colourless to pale yellow solution, free from visible particulates.; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorizācija statuss:

Licence status A

Autorizācija datums:

2009-02-11